<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04222179</url>
  </required_header>
  <id_info>
    <org_study_id>IRB106-10-A</org_study_id>
    <nct_id>NCT04222179</nct_id>
  </id_info>
  <brief_title>One Brand-new Maneuver to Place Nasoenteric Tube</brief_title>
  <official_title>Tzu-chi General Hospital,Hualien County,Taiwan,ROC</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Buddhist Tzu Chi General Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Buddhist Tzu Chi General Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Naso-enteric tube feeding is necessary for certain patients. Many methods are used to place a
      naso-enteric tube, such as bed-side blind method, fluoroscopy method and guide-wire method.
      INvestigators aim to introduce a safe, non-expensive and fast method to insert a silicon
      naso-gastric (NG) tube into the small intestine.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Investigators tied a 1-cm surgical suture at the tip of a 16 French silicon NG tube (120 cm
      long, cost 5 US dollars). One conventional EGD (diameter 2.8 mm) biopsy forceps was inserted
      into the lumen as a strengthened stylet. Then investigators inserted a biopsy forceps
      (diameter 2.0 mm) and protruded a little out of the working channel of an ultrathin EGD scope
      (Fujinon EG 530 N, diameter 5.9 mm) to grasp the suture. The ultrathin EGD and NG tube were
      parallelly pushed into a selected nostril after adequate decongestive anesthesia (Epinephrine
      0.3% + Lidocaine 5%) into the small intestine as deep as possible to the jejunum.

      Being placed to the small intestine as far as possible, the NG tube was released and the
      ultrathin EGD scope withdrew. When the scope was pulled backwards from the stomach, the
      shape/layout of a NG-tube could be simultaneously monitored and adjusted. At last, the EGD
      biopsy forceps (2.8 mm) inside the NG tube was removed. With this method, in real life, a
      plain film is not necessary to confirm the NG tube position. However, for study purpose, a
      KUB film was taken to check the NG tube position.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">December 31, 2020</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2020</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>procedure time</measure>
    <time_frame>wıthın 20 mınutes</time_frame>
    <description>The procedure times to place the tube are recorded</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>the tıme of naso-enterıc tube usage</measure>
    <time_frame>within 90 days</time_frame>
    <description>The tıme of the naso-enteric tube was recorded in day</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Nutrient Intake Disorder</condition>
  <arm_group>
    <arm_group_label>Naso-enteric tube placement</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>The participants needed nutrition from naso-enteric tube feeding are enrolled into this study. Double-blind was not needed here.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>ultrathın esophagogastroduodenoscope</intervention_name>
    <description>Place the naso-enteric tube together with the ultrathin esophagogastroduodenoscope from the same nasal cavity</description>
    <arm_group_label>Naso-enteric tube placement</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Esophageal obstruction

          2. Gastric outlet obstruction

          3. Duodenal obstruction

          4. Pancreatitis

          5. Gastroparesis -

        Exclusion Criteria:

          -  (1)Coagulopathy (2)Deviation of nasal septa (3)Conscious disturbance
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Jen S Lin, VS</last_name>
    <role>Study Director</role>
    <affiliation>Buddhist Tzu Chi General Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jen S Lin, VS</last_name>
    <phone>886-3-8561825</phone>
    <phone_ext>13224</phone_ext>
    <email>labyrinth68306830@icloud.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Chi T Hu, VS</last_name>
    <phone>886-3-8561825</phone>
    <phone_ext>13224</phone_ext>
    <email>chitan.hu@msa.hinet.net</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tzu-chi Hospital</name>
      <address>
        <city>Hualien City</city>
        <state>Hua-lien County</state>
        <zip>97002</zip>
        <country>Taiwan</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Jen S Lin, VS</last_name>
      <phone>886-3-8561825</phone>
      <phone_ext>13224</phone_ext>
      <email>labyrinth68306830@icloud.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>July 2020</verification_date>
  <study_first_submitted>January 2, 2020</study_first_submitted>
  <study_first_submitted_qc>January 7, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">January 9, 2020</study_first_posted>
  <last_update_submitted>July 8, 2020</last_update_submitted>
  <last_update_submitted_qc>July 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">July 10, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Buddhist Tzu Chi General Hospital</investigator_affiliation>
    <investigator_full_name>Jen-Shung Lin</investigator_full_name>
    <investigator_title>Prıncıpal ınvestıgator</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

